Urolog. pro Praxi, 2010; 11(1): 29-31 [Interní Med. 2009; 11(11): 515-517]

Medication of erectile dysfunction and its security

doc.MUDr.Michal Pohanka, Ph.D.1, prof.MUDr.RNDr.Luboslav Stárka, DrSc.2
1 Gynekologicko-porodnická klinika FN Brno a Sexuologický ústav 1. LF UK, Praha
2 Endokrinologický ústav, Praha

Erectile dysfunction is a relatively frequent disorder substantially increasing with age. The high effective treatment of erectile dysfunction

by drugs based on inhibition of phosphodiesterases type 5 (sildenafil, tadalafil, vardenafil) tempt to prescription of these drugs

without careful examination. It is demanded to include besides personal history and physical examination also laboratory data for exclusion

of diseases associated with erectile dysfunction as diabetes mellitus, hyperprolactinemia or hypogonadismus. Contraindicated

for treatment by inhibitors of phophodiesterases are nitrates. For patients on intensive antihypertension therapy or with severe cardiac

diseases cardiovascular examination is a rule. The physician should made the patient acquainted with side-effects as headaches, flush,

dyspepsia, nasal mucosal congestion, low-back aches, changes in colour vision, and, especially with the rare but still existent possibility

of priapism, which needs an urological intervention.

Keywords: erectile dysfunction, inhibitors of phosphodiesterases, contraindications, side-efects, examination

Published: March 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pohanka M, Stárka L. Medication of erectile dysfunction and its security. Urol. praxi. 2010;11(1):29-31.
Download citation

References

  1. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007; 120 (2): 151-157. Go to original source... Go to PubMed...
  2. Johannes CB, Araujo AB, Feldman HA, et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol. 2000; 163 (2): 460-463. Go to original source... Go to PubMed...
  3. Hill KD, Eckhauser AW, Marney A, Brown NJ. Phosphodiesterase 5 inhibition improves beta-cell function in metabolic syndrome. Diabetes Care 2009; 32 (5): 857-859. Go to original source... Go to PubMed...
  4. Ferrini MG, Magee TR, Vernet D, et al. Penile neuronal nitric oxide synthase and its regulatory proteins are present in hypothalamic and spinal cord regions involved in the control of penile erection. J Comp Neurol. 2003; 458: 46-61. Go to original source... Go to PubMed...
  5. Jarabák J, Zachoval R. Erektilní dysfunkce a metabolický syndrom. Postgrad. Med. 2008; 10: 391-393.
  6. Kratochvíl S. Sexuální dysfunkce, příčiny a léčba. Praha, Grada Publishing: 2008: 299 s.
  7. Kubíček V. Mužská infertilita a erektilní dysfunkce, Praha, Galén: 1996: 148 s.
  8. Lewis JH, Rosen R, Goldstein I. Consensus Panel on Health Care Clinician Management of Erectile Dysfunction. Erectile dysfunction. Am J Nurs. 2003; 103(10): 48-57. Go to original source... Go to PubMed...
  9. Lue TF, Giuliano F, Montorsi F, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004; 1 (1): 6-23. Go to original source... Go to PubMed...
  10. Morelli A, Vignozzi L, Filippi S, et al. Erectile dysfunction: molecular biology, pathophysiology and pharmacological treatment. Minerva Urol Nefrol. 2005; 57: 85-90. Go to PubMed...
  11. Sánchez A, Villalba N, Martínez AC, et al. Mechanisms of the relaxant effect of vardenafil in rat penile arteries. Eur J Pharmacol. 2008; 586 (1-3): 283-287. Go to original source... Go to PubMed...
  12. Toque HA, Teixeira CE, Priviero FB, et al. Vardenafil, but not sildenafil or tadalafil, has calcium-channel blocking activity in rabbit isolated pulmonary artery and human washed platelets. Br J Pharmacol. 2008; 154 (4): 787-796. Go to original source... Go to PubMed...
  13. Urban M, Heráček J, Báča V. Chronická pánevní bolest a sexuální funkce pohledem urologa a anatoma. Postgrad. Med. 2008; 10: 394-402.
  14. Valentová K, Entnerová P, Urbaníková J, Šimánek V. Chemie mužské sexuality. Chem. Listy 2004; 98: 1119-1129.
  15. Zámečník L. Erektilní dysfunkce. Postgrad Med. 2008; 10: 383-390.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.